AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $95.49
- 52-wk low
- $20.45
- Prev close
- $58.87
- Mkt cap
- $12.36B
- Fwd P/E
- 111.1x
- Beta
- 1.29
Smart money
Earnings
Earnings came in 10.6% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $256.5M | $264.0M | $73.7M | $75.3M |
| Cost of what it sold | $6.4M | $6.4M | $6.4M | — |
| Gross profit | $256.5M | $264.0M | $73.7M | $75.3M |
| What it spent | ||||
| Research and development | $174.7M | $177.2M | $173.3M | $198.2M |
| Sales and admin | $37.2M | $45.5M | $41.2M | $46.6M |
| Total operating expenses | $212.4M | $223.2M | $215.0M | $245.3M |
| What was left | ||||
| Operating profit | $44.1M | $40.8M | -$141.3M | -$170.1M |
| Interest on debt | $21.7M | $22.5M | $23.8M | $24.6M |
| Profit before tax | $36.1M | $28.3M | -$137.6M | -$178.9M |
| Tax | $20.0M | $29.0K | $7.0K | $11.0K |
| Net profit | -$23.8M | $30.8M | -$132.7M | -$194.3M |
| EBITDA | $64.2M | $57.2M | -$107.4M | -$154.3M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
13 articles · 7 days
Coverage leans bullish
Tone of tracked coverage
Arrowhead (NASDAQ: ARWR) director to sell 2,000 shares
NeutralAug 18Arrowhead (NASDAQ: ARWR) director to sell 11,600 shares
NeutralAug 18ETFs Investing in Arrowhead Pharmaceuticals, Inc. Stocks
NeutralAug 17
